Results 31 to 40 of about 4,517,311 (361)

Anticoagulation Therapy

open access: yesHematology, 2001
Abstract Despite refinements and standardization in the use of anticoagulants, many problems remain for clinicians. Dr. Crowther describes appropriate starting and maintenance doses of warfarin, factors accounting for inter- and intra-observer variability and importantly, the management of the over-anticoagulated patients and bleeding ...
J A, Ginsberg   +3 more
openaire   +2 more sources

Bleeding in a COVID-19 Patient; Rectus Hematoma

open access: yesNorthwestern Medical Journal, 2021
Anticoagulant therapy is part of the treatment of hospitalized COVID-19 patients. Low molecular weight heparin or oral anticoagulant drugs are used in its treatment. However this approach may increase the risks of bleeding.
Kader Zeybek Aydoğan   +2 more
doaj   +1 more source

Optimizing Warfarin Dosing using Deep Reinforcement Learning [PDF]

open access: yesJournal of Biomedical Informatics, 137 (2023) 104267, 2022
Warfarin is a widely used anticoagulant, and has a narrow therapeutic range. Dosing of warfarin should be individualized, since slight overdosing or underdosing can have catastrophic or even fatal consequences. Despite much research on warfarin dosing, current dosing protocols do not live up to expectations, especially for patients sensitive to ...
arxiv   +1 more source

Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice

open access: yesРациональная фармакотерапия в кардиологии, 2020
Aim. To study the frequency of prescribing anticoagulant therapy in outpatients with AF in accordance with clinical guidelines.Material and methods. Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF) observational study was conducted at ...
A. A. Zarudsky   +2 more
doaj   +1 more source

PATTERN OF ANTICOAGULANT THERAPY IN CARDIOEMBOLIC STROKE

open access: yesMalang Neurology Journal, 2023
Background: Cardioembolic stroke is a category of ischemic stroke that manifests more severe, is prone to recurrence, and is related to a higher mortality rate than the other categories of ischemic stroke.
Reihan Achmad Reza   +4 more
doaj   +1 more source

Trend of anticoagulant therapy in elderly patients with atrial fibrillation considering risks of cerebral infarction and bleeding

open access: yesScientific Reports, 2023
The introduction of direct oral anticoagulants (DOACs) has greatly changed the use of anticoagulant therapy in patients with non-valvular atrial fibrillation (Af).
Noriko Tsuji   +8 more
doaj   +1 more source

Prediction of need for bowel resection in acute superior mesenteric artery occlusion: A retrospective study of 48 Japanese patients

open access: yesAnnals of Gastroenterological Surgery, Volume 7, Issue 1, Page 175-181, January 2023., 2023
In a study of 48 patients with acute superior mesenteric artery occlusion, a logistic regression model using time from onset to diagnosis and the occlusion site of superior mesenteric artery showed 78.6% sensitivity in ruling out cases requiring bowel resection.
Susumu Watada   +9 more
wiley   +1 more source

Perioperative management of anticoagulant therapy

open access: yesInnovative Surgical Sciences, 2019
About 10% of patients taking a chronic, oral anticoagulant therapy require an invasive procedure that can be associated with an increased risk for peri-interventional or perioperative bleeding.
Wagner Johanna   +7 more
doaj   +1 more source

Treatment of bleeding complications in patients on anticoagulant therapy.

open access: yesBlood, 2019
Anticoagulant therapy is often refrained from out of fear of hemorrhagic complications. The most frequent type of major bleeding is gastrointestinal, but intracranial hemorrhage has the worst prognosis.
Siavash Piran, S. Schulman
semanticscholar   +1 more source

The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysisResearch in context

open access: yesEClinicalMedicine, 2023
Summary: Background: The optimal duration of anticoagulation in patients with active cancer and venous thromboembolism (VTE) is unknown. Current clinical guidelines advocate anticoagulant therapy for 3–6 months and to continue anticoagulant therapy for ...
Marte A.M. van Hylckama Vlieg   +22 more
doaj  

Home - About - Disclaimer - Privacy